THE CONTRACEPTIVE EFFECTS OF ETOPRINE ON MALE-MICE AND RATS

被引:0
作者
MALIK, NS
MATLIN, SA
FRIED, J
PAKYZ, RE
CONSENTINO, MJ
机构
[1] MILLERSVILLE UNIV PENNSYLVANIA,DEPT BIOL,MILLERSVILLE,PA 17551
[2] UNIV WARWICK,DEPT CHEM,COVENTRY,W MIDLANDS,ENGLAND
[3] UNIV CHICAGO,DEPT CHEM,CHICAGO,IL 60637
来源
JOURNAL OF ANDROLOGY | 1995年 / 16卷 / 02期
关键词
ETOPRINE; MALE CONTRACEPTION; SPERMATOGENESIS; DIHYDROFOLATE REDUCTASE;
D O I
暂无
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
We had previously found that 2,4-diaminopyrimidines affected spermatogenesis, possibly through the inhibition of testicular dihydrofolate reductase (DHFR). The current study examined the effects of etoprine, a highly lipophilic 2,4-diaminopyrimidine that is also a potent DHFR inhibitor, on the fertility of male mice at various dosages (0.1-50 mg/kg/day) for 55 days and male rats at 5 mg/kg/ day for 65 days. Two other substituted diaminopyrimidines were tested at dosages of 50 mg/kg/day for 55 days. Results of breeding trials along with assessment of various parameters indicative of male fertility were noted. We found that of the compounds tested, etoprine is a potent antifertility agent that causes complete infertility at doses of greater than or equal to 5 mg/kg/day in mice with a threshold of effectiveness occurring between 1 and 5 mg/kg/day. The antifertility action of etoprine may be related to its capacity to inhibit testicular DHFR and its high degree of lipophilicity.
引用
收藏
页码:169 / 174
页数:6
相关论文
共 17 条
[1]   DAILY SPERMATOZOAL PRODUCTION, EPIDIDYMAL SPERMATOZOAL RESERVES AND TRANSIT-TIME OF SPERMATOZOA THROUGH EPIDIDYMIS OF RHESUS-MONKEY [J].
AMANN, RP ;
JOHNSON, L ;
THOMPSON, DL ;
PICKETT, BW .
BIOLOGY OF REPRODUCTION, 1976, 15 (05) :586-592
[2]  
AWONIYI CA, 1993, J ANDROL, V14, P174
[3]   STRUCTURE ACTIVITY RELATIONSHIPS OF DIHYDROFOLATE-REDUCTASE INHIBITORS [J].
BLANEY, JM ;
HANSCH, C ;
SILIPO, C ;
VITTORIA, A .
CHEMICAL REVIEWS, 1984, 84 (04) :333-407
[4]  
BURCHALL JJ, 1965, MOL PHARMACOL, V1, P126
[5]  
CAVALLITO JC, 1978, DRUG METAB DISPOS, V6, P329
[6]  
COSENTINO MJ, 1986, J ANDROL, V7, P23
[7]   PYRIMETHAMINE - AN APPROACH TO THE DEVELOPMENT OF A MALE CONTRACEPTIVE [J].
COSENTINO, MJ ;
PAKYZ, RE ;
FRIED, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) :1431-1435
[8]   LOW-DOSE METHOTREXATE KINETICS IN ARTHRITIS [J].
EDELMAN, J ;
BIGGS, DF ;
JAMALI, F ;
RUSSELL, AS .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (03) :382-386
[9]  
HANSEN SW, 1992, DAN MED BULL, V39, P391
[10]  
HILL BT, 1977, EUR J CANCER, V15, P861